Stocks and Investing
Stocks and Investing
Tue, April 18, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, April 17, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matt O"Brien Initiated (STAA) at Hold and Held Target at $65 on, Apr 17th, 2023
Matt O"Brien of Piper Sandler, Initiated "STAAR Surgical Company" (STAA) at Hold and Held Target at $65 on, Apr 17th, 2023.
Matt has made no other calls on STAA in the last 4 months.
There are 5 other peers that have a rating on STAA. Out of the 5 peers that are also analyzing STAA, 1 agrees with Matt"s Rating of Hold. Following is the relevant analyst calls for the last 4 months;
Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Monday, February 6th, 2023
These are the ratings of the 4 analyists that currently disagree with Matt;
David Saxon of "Needham" Maintained at Strong Buy with Decreased Target to $78 on, Wednesday, February 22nd, 2023 George Sellers of "Stephens & Co." Reiterated at Buy and Held Target at $85 on, Wednesday, February 22nd, 2023 Bruce Jackson of "Benchmark" Maintained at Strong Buy with Decreased Target to $75 on, Wednesday, February 1st, 2023 William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $80 on, Monday, January 30th, 2023
Contributing Sources